← Back
Data updated: Jul 17, 2026
XANODYNE PHARMS INC
Pharma Pharmaceuticals
XANODYNE PHARMS INC is a pharmaceutical company with 1 FDA-approved products.
1991
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
XANODYNE PHARMS INC's Key Drugs
XANODYNE PHARMS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
XANODYNE PHARMS INC's Recent FDA Approvals
New NDA/BLA approvals for XANODYNE PHARMS INC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
XANODYNE PHARMS INC's Therapeutic Areas
Disease areas where XANODYNE PHARMS INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
XANODYNE PHARMS INC Pipeline Snapshot
Active clinical trials for XANODYNE PHARMS INC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1991-08-15
- Latest
- 2001-07-13
- Applications
- 1